文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

多西环素与阿奇霉素治疗男男性行为者直肠衣原体感染:随机对照试验

Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial.
PubMed 文献 · Clin Infect Dis · 2021-01-01

这项随机双盲安慰剂对照试验比较了阿奇霉素单剂1g与多西环素100mg每日两次连用7天治疗男男性行为者直肠沙眼衣原体感染的效果。结果显示多西环素在符合方案人群(100% vs 74%)和意向治疗人群(91% vs 71%)中的微生物学治愈率均显著高于阿奇霉素。

要点

  • 多西环素7天方案治疗直肠衣原体的微生物学治愈率显著优于阿奇霉素单剂。
  • 符合方案人群中多西环素治愈率100%,阿奇霉素74%,绝对差异26%。
  • 意向治疗人群中多西环素治愈率91%,阿奇霉素71%,绝对差异20%。

核心结论

  • 一周多西环素方案治疗MSM直肠CT感染的微生物学治愈率显著高于单剂阿奇霉素。

研究设计与样本

  • 随机双盲安慰剂对照试验,在Seattle和Boston招募MSM,纳入177例临床诊断直肠CT感染者。
  • 参与者在入组时及入组后2周和4周重复采集直肠拭子进行NAAT检测。
  • 主要结局为4周时微生物学治愈(NAAT阴性)。

主要发现

  • 符合方案人群(135例)中,多西环素组治愈率100%(70/70),阿奇霉素组74%(48/65),绝对差异26%(95%CI 16-36%,P<.001)。
  • 意向治疗人群(177例)中,多西环素组治愈率91%(80/88),阿奇霉素组71%(63/89),绝对差异20%(95%CI 9-31%,P<.001)。

关键数值与推荐

  • 多西环素用法:100mg每日两次,连用7天。
  • 阿奇霉素用法:单剂1g。
  • 主要结局定义:4周时直肠NAAT CT阴性。

临床怎么用

  • 对于MSM直肠CT感染,可优先考虑多西环素7天方案以提高微生物学治愈率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Azithromycin and doxycycline are both recommended treatments for rectal Chlamydia trachomatis (CT) infection, but observational studies suggest that doxycycline may be more effective. METHODS: This randomized, double-blind, placebo-controlled trial compared azithromycin (single 1-g dose) versus doxycycline (100 mg twice daily for 7 days) for the treatment of rectal CT in men who have sex with men (MSM) in Seattle and Boston. Participants were enrolled after a diagnosis of rectal CT in clinical care and underwent repeated collection of rectal swabs for nucleic acid amplification testing (NAAT) at study enrollment and 2 weeks and 4 weeks postenrollment. The primary outcome was microbiologic cure (CT-negative NAAT) at 4 weeks. The complete case (CC) population included participants with a CT-positive NAAT at enrollment and a follow-up NAAT result; the intention-to-treat (ITT) population included all randomized participants. RESULTS: Among 177 participants enrolled, 135 (76%) met CC population criteria for the 4-week follow-up visit. Thirty-three participants (19%) were excluded because the CT NAAT repeated at enrollment was negative. Microbiologic cure was higher with doxycycline than azithromycin in both the CC population (100% [70 of 70] vs 74% [48 of 65]; absolute difference, 26%; 95% confidence interval [CI], 16-36%; P < .001) and the ITT population (91% [80 of 88] vs 71% [63 of 89]; absolute difference, 20%; 95% CI, 9-31%; P < .001). CONCLUSIONS: A 1-week course of doxycycline was significantly more effective than a single dose of azithromycin for the treatment of rectal CT in MSM. CLINICAL TRIALS REGISTRATION: NCT03608774.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dombrowski JC, Wierzbicki MR, Newman LM, et al. Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial. Clin Infect Dis. 2021. PMID: 33606009. doi:10.1093/cid/ciab153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。